Genetic variability of the distal promoter of the ST2 gene is associated with angiographic severity of coronary artery disease

Journal of Thrombosis and Thrombolysis

Volumn 30, Issue 3, 2010, Pages 365-371

  Tsapaki, Andy ^a   Zaravinos, Apostolos ^a   Apostolakis, Stavros ^a   Voudris, Konstantinos ^a   Vogiatzi, Konstantina ^a   Kochiadakis, Georgios E ^b   Spandidos, Demetrios A ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

Author keywords

Coronary artery disease; Interleukin 33; Polymorphisms; ST2

Indexed keywords

INTERLEUKIN 1 RECEPTOR; PROTEIN ST2; UNCLASSIFIED DRUG;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DATA COLLECTION; DATABASES, NUCLEIC ACID; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RECEPTORS, CELL SURFACE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77957949209     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-010-0496-y     Document Type: Article

References (14)

1. S Apostolakis K Vogiatzi E Krambovitis DA Spandidos 2008 IL-1 cytokines in cardiovascular disease: diagnostic, prognostic and therapeutic implications Cardiovasc Hematol Agents Med Chem 6 150 158 1:CAS:528:DC%2BD1cXjsVKhurg%3D 10.2174/187152508783955006 18473780 (Pubitemid 351935022)
2. J Schmitz A Owyang E Oldham Y Song E Murphy TK McClanahan G Zurawski M Moshrefi J Qin X Li DM Gorman JF Bazan RA Kastelein 2005 IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 479 490 1:CAS:528:DC%2BD2MXht12msr7K 10.1016/j.immuni.2005.09.015 16286016 (Pubitemid 41587888)
3. V Trajkovic MJ Sweet D Xu 2004 T1/ST2-an IL-1 receptor-like modulator of immune responses Cytokine Growth Factor Rev 15 87 95 1:CAS:528: DC%2BD2cXjsVWnurg%3D 10.1016/j.cytogfr.2004.02.004 15110792 (Pubitemid 38523333)
4. M Ali G Zhang WR Thomas CJ McLean JA Bizzintino IA Laing AC Martin J Goldblatt PN Le Souëf CM Hayden 2009 Investigations into the role of ST2 in acute asthma in children Tissue Antigens 73 206 212 1:CAS:528: DC%2BD1MXjvFOisrk%3D 10.1111/j.1399-0039.2008.01185.x 19254249
5. M Shimizu A Matsuda K Yanagisawa T Hirota M Akahoshi N Inomata K Ebe K Tanaka H Sugiura K Nakashima M Tamari N Takahashi K Obara T Enomoto Y Okayama PS Gao SK Huang S Tominaga Z Ikezawa T Shirakawa 2005 Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis Hum Mol Genet 14 2919 2927 1:CAS:528:DC%2BD2MXhtVWnt7nP 10.1093/hmg/ddi323 16118232 (Pubitemid 41418796)
6. K Vogiatzi S Apostolakis V Voudris S Thomopoulou GE Kochiadakis DA Spandidos 2010 Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary intervention J Thromb Thrombolysis 29 134 140 1:CAS:528:DC%2BC3cXivFyjsw%3D%3D 10.1007/s11239-009-0338-y 19404719
7. Third Joint Task Force of European Other Societies on Cardiovascular Disease Prevention in Clinical Practice 2003 European guidelines on cardiovascular disease prevention in clinical practice Eur J Cardiovasc Prev Rehabil 10 1 78
8. P Kanellou A Zaravinos M Zioga A Stratigos S Baritaki G Soufla O Zoras DA Spandidos 2008 Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis Cancer Lett 264 145 161 1:CAS:528:DC%2BD1cXls12ju7s%3D 10.1016/j.canlet.2008.01.042 18331779
9. A Zaravinos J Bizakis G Soufla G Sourvinos DA Spandidos 2007 Mutations, differential expression of the ras family genes in human nasal polyposis Int J Oncol 31 1051 1:CAS:528:DC%2BD2sXhtlKhsrbE 17912430
10. S Sanada D Hakuno LJ Higgins ER Schreiter AN McKenzie RT Lee 2007 IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system J Clin Investig 117 1538 1549 1:CAS:528:DC%2BD2sXmsVWkur4%3D 10.1172/JCI30634 17492053 (Pubitemid 46871338)
11. EO Weinberg M Shimpo GW De Keulenaer, et al. 2002 Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction Circulation 106 2961 2966 1:CAS:528: DC%2BD38XovVeltrY%3D 10.1161/01.CIR.0000038705.69871.D9 12460879 (Pubitemid 35424749)
12. AM Brown AH Wu P Clopton JL Robey JE Hollander 2007 ST2 in emergency department chest pain patients with potential acute coronary syndromes Ann Emerg Med 50 153 158 10.1016/j.annemergmed.2007.02.015 17466411 (Pubitemid 47069601)
13. DA Pascual-Figal J Ordoñez-Llanos PL Tornel R Vázquez T Puig M Valdés J Cinca AB de Luna A Bayes-Genis MUSIC Investigators 2009 Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction J Am Coll Cardiol 54 2174 2179 1:CAS:528:DC%2BC3cXkvFOhsQ%3D%3D 10.1016/j.jacc.2009.07.041 19942089
14. A Martinez-Rumayor CA Camargo SM Green AL Baggish M O'Donoghue JL Januzzi 2008 Soluble ST2 plasma concentrations predict 1-year mortality in acutely dyspneic emergency department patients with pulmonary disease Am J Clin Pathol 130 578 584 10.1309/WMG2BFRC97MKKQKP 18794051